Texas Instruments (TXN) stock price rises as inflation cools; insider sales hit SEC filings

February 14, 2026
Texas Instruments (TXN) stock price rises as inflation cools; insider sales hit SEC filings

New York, Feb 13, 2026, 17:54 ET — Trading after the bell.

Texas Instruments Incorporated (TXN) climbed 1.5% to $226.16 late Friday, tracking gains across chip stocks after a batch of insider-trading filings and lighter inflation figures. The Philadelphia semiconductor index advanced roughly 0.9% for the session. Analog Devices rose; Microchip Technology fell.

U.S. equities found their footing as January’s consumer price data landed softer than forecast, giving traders more reason to price in a 25-basis-point (0.25 percentage point) Federal Reserve rate cut come June, CME Group’s FedWatch tool showed. But tech names faded in late trading ahead of the Presidents Day break. “Any whiff of optimism continues to get rejected,” said Michael James, managing director at Rosenblatt Securities in Los Angeles. Reuters

Texas Instruments shares have gotten choppy, more than their usual pace. The stock often moves as a proxy for factory and auto demand, so investors are jumping at any signs of positioning—routine or not.

CFO Rafael R. Lizardi exercised stock options and unloaded 71,628 shares over several trades on Feb. 10 and Feb. 11, according to a Form 4 just filed with the U.S. Securities and Exchange Commission. Sale prices landed in a band from about $220 to $231 per share, generating roughly $15.9 million in proceeds, the document shows.

Senior Vice President Mark Gary unloaded 23,169 shares on Feb. 10 and Feb. 11, raking in about $5.24 million, according to a Form 4 filing. Part of the sale followed an option exercise. Post-sale, Gary’s reported stake stood at 45,547 shares.

Senior Vice President Ahmad Bahai sold 6,500 shares on Feb. 11 after exercising options, according to a separate filing. The transaction, done at a weighted-average price near $230.79, was worth about $1.50 million. After the sale, Bahai reported holding 42,488 shares.

Insider trades hit the tape as investors weigh Texas Instruments’ latest move into wireless chips. On Feb. 4, the company announced a $7.5 billion cash deal to acquire Silicon Labs at $231 per share. CEO Haviv Ilan described the acquisition as “a significant milestone” for TI’s embedded processing strategy. Texas Instruments

Investors are moving past Form 4s and zeroing in on the numbers that count: the company’s appetite for debt, its stance on buybacks versus dividends, and just how tightly it will keep a lid on spending if demand falters.

If rate-cut optimism unravels or the rally keeps shifting out of pricey tech and chip stocks, things could deteriorate quickly. A weaker tape tends to amplify the noise around insider selling, and just a hiccup in a major deal might dent sentiment long before the fundamentals catch up.

Up next: timing. U.S. exchanges take a break Monday, Feb. 16 for Washington’s Birthday, so trading resumes Tuesday for a shortened stretch. Meanwhile, Texas Instruments lines up its capital management webcast for Feb. 24 at 10 a.m. Central, where Ilan and CFO Lizardi are expected to detail their strategy on free cash flow and boosting returns to shareholders.

Stock Market Today

  • Tuas (ASX:TUA) Shares Plunge After Regulatory Suspension of M1 Acquisition Review
    May 23, 2026, 1:20 AM EDT. Shares of Tuas (ASX:TUA) plunged over 60% in a week following the suspension of Singapore's regulatory review into its planned M1 acquisition amid unauthorized spectrum use allegations. The stock trades at a high price-to-earnings (P/E) ratio of 95.4x, well above the global telecom average of 16.7x, reflecting optimism despite ongoing risks. Despite short-term losses, Tuas retains a 5-year total shareholder return of 255%, highlighting resilient long-term performance. Analysts note mixed signals with strong recent earnings growth countered by low return on equity and one-off losses. The uncertainty about spectrum issues and the acquisition review continue to cloud the outlook, with discounted cash flow models valuing the stock slightly below current prices. Investors are reassessing fundamentals amid this regulatory shock impacting sentiment.